Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study - Gouw, S C; van der Bom, J G; Auerswald, G; Ettinghausen, C E; Tedgård, U; van den Berg, H M (Blood, 2007)